Termeer bound for private equity firm? Jennerex touts early results for cancer-fighting virus;

@FierceBiotech: Sanofi finally nails $20B+ deal to buy Genzyme. Report

@JohnCFierce: True, Sanofi didn't invent the CVR. But dealmakers believe that even cash-heavy pharma companies will be more likely to use them post-Genzyme. Follow @JohnCFierce 

> If the experiences of other ex-CEOs are any indication of what lies in store for Henri Termeer after he wraps up his long stint at Genzyme, you shouldn't be too surprised to see him land a cozy spot with a prominent private equity group. Report

> San Francisco-based Jennerex tells Xconomy that a small study of its cancer-fighting virus is demonstrating some positive results against liver cancer. Report

> Merck Serono has withdrawn its European application for the MS drug cladribine. Story

And Finally... A team led by researchers from UCLA and the Veterans Administration that was investigating how stress affects gastrointestinal function may have found a chemical compound that induces hair growth by blocking a stress-related hormone associated with hair loss--entirely by accident. Report